BCL2 Antibody

B-Cell Leukemia/Lymphoma 2, Mouse Anti Human
Cat. No.
BT13001
Source
Synonyms
Apoptosis regulator Bcl-2, BCL2, B-cell CLL/lymphoma 2, Bcl-2.
Appearance
Purity
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Product Specs

Introduction
The BCL2 gene produces a protein found on the outer membrane of mitochondria. This protein prevents cell death (apoptosis) in certain cells, including lymphocytes. When BCL2 is constantly produced, for example, due to a translocation to the Ig heavy chain locus, it can lead to a type of cancer called follicular lymphoma. There are two slightly different versions of the BCL2 protein, which arise from alternative splicing of the gene transcript.
Formulation
The antibody is supplied at a concentration of 1mg/ml in a solution containing PBS at a pH of 7.4 and 0.1% Sodium Azide.
Storage Procedures
For storage up to 1 month, the antibody can be kept at 4°C. For longer-term storage, it is recommended to store at -20°C. Avoid repeated freezing and thawing.
Stability / Shelf Life
The antibody is stable for 12 months when stored at -20°C and for 1 month at 4°C.
Applications
The BCL2 antibody has been validated for use in ELISA, Western blot, and Immunofluorescence assays, demonstrating its specificity and reactivity. However, as experimental conditions can vary, optimization of the antibody concentration is recommended for each application. For Western blot and Immunofluorescence, a dilution range of 1:250 to 1:500 is suggested. A starting dilution of 1:500 is recommended.
Synonyms
Apoptosis regulator Bcl-2, BCL2, B-cell CLL/lymphoma 2, Bcl-2.
Purification Method
BCL2 antibody was purified from mouse ascitic fluids by protein-G affinity chromatography.
Type
Mouse Anti Human Monoclonal.
Clone
PAT1B5AT.
Immunogen
Anti-human BCL2 mAb, is derived from hybridization of mouse FO myeloma cells with spleen cells from BALB/c mice immunized with recombinant human BCL2 amino acids 1-211 purified from E. coli.
Ig Subclass
Mouse IgG2b heavy chain and k light chain.

Product Science Overview

Introduction

B-Cell Leukemia/Lymphoma 2 (BCL-2) is a key protein regulator of apoptosis, which is the process of programmed cell death. The BCL-2 protein is encoded by the BCL2 gene in humans and is the founding member of the BCL-2 family of regulator proteins. This family includes both pro-apoptotic and anti-apoptotic proteins that play crucial roles in the regulation of cell death and survival .

Discovery and Function

The BCL-2 gene was first identified in chromosomal translocations involving chromosomes 14 and 18 in follicular lymphomas. This translocation results in the overexpression of the BCL-2 protein, which inhibits apoptosis and allows cells to survive longer than they should, contributing to the development of cancer .

BCL-2 is localized to the outer membrane of mitochondria, where it promotes cellular survival by inhibiting the actions of pro-apoptotic proteins such as Bax and Bak. These pro-apoptotic proteins normally act on the mitochondrial membrane to promote permeabilization and release of cytochrome c and reactive oxygen species (ROS), which are important signals in the apoptosis cascade .

Role in Disease

Damage to the BCL-2 gene has been identified as a cause of several cancers, including melanoma, breast cancer, prostate cancer, chronic lymphocytic leukemia, and lung cancer. Overexpression of BCL-2 alone does not cause cancer, but when combined with the overexpression of the proto-oncogene myc, it can lead to aggressive B-cell malignancies, including lymphoma .

Therapeutic Development

The development of BCL-2 inhibitors has been a significant advancement in cancer therapy. Venetoclax is the first selective BCL-2 inhibitor and has been approved for the treatment of chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). Venetoclax works by inhibiting BCL-2, thereby triggering apoptosis in cancer cells .

Mouse Anti-Human BCL-2 Antibody

The mouse anti-human BCL-2 antibody is derived from the hybridization of mouse FO myeloma cells with spleen cells from BALB/c mice immunized with recombinant human BCL-2 amino acids 1-211 purified from E. coli . This antibody is used in research to study the expression and function of BCL-2 in various human tissues and cells.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.